Rx for Biotech

By Podcast Host Chris LeidliBusiness

Rx for Biotech episodes

June 02, 2022 Chandra Ramanathan, PhD on How to Create Value through Innovation Ecosystems
In this episode, Dr. Ramanathan discusses best practices in Pharmaceutical, Biotechnology, and Academic partnerships, alliance management, and innovation.
24 min
May 23, 2022 Chris Dokomajilar on Trends in Life Science Investing, M&A and Partnering
The biopharma ecosystem is devoting significant resources to develop novel cell and gene therapies to treat cancer. In this episode of "Rx for Biotech", Chris Dokomajilar discusses trends in Biotechnology investment, licensing and partnering landscape and provides an outlook on what to expect for the remainder of 2022.
25 min
June 20, 2020 CRISPR and Gene Editing for Human Disease
Our guest in this episode is Dr. Andrew Garst. We discuss the technology behind powerful new genome editing tools that are driving new therapies to treat genomic and inherited human diseases.
28 min
May 19, 2020 The Future of Cell and Gene Therapies
During this episode, we explore the key opportunities and challenges with the future commercialization of innovative personalized therapies with our guest, Michael Amoroso, a leader in the cell and gene therapy industry.
43 min
May 01, 2020 Regulatory Challenges in Biotech
In this episode, Dr. Katie Graham reviews FDA regulatory review process for innovative new biotechnology and pharmaceutical products. Dr. Graham shares best practices in helping emerging biotechnology companies accelerate their organizational launch readiness.
29 min

About Rx for Biotech

From the publisher's feed

"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care.